PUBLISHER: TechSci Research | PRODUCT CODE: 2046164
PUBLISHER: TechSci Research | PRODUCT CODE: 2046164
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The global ophthalmic lasers market is projected to grow from USD 1.92 billion in 2025 to USD 2.73 billion by 2031, at a 6.04% CAGR. These specialized medical devices use focused light energy for non-invasive or minimally invasive surgical treatments of conditions such as cataracts, glaucoma, and refractive errors. Market expansion is driven by a globally aging population and increasing chronic eye diseases requiring surgery, as evidenced by a 14% rise in eye exam market value in Q2 2025, according to The Vision Council, indicating growing diagnostic activity preceding laser treatments. However, high acquisition costs for advanced laser platforms challenge market growth, deterring smaller facilities and limiting penetration in developing regions with constrained budgets.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.92 Billion |
| Market Size 2031 | USD 2.73 Billion |
| CAGR 2026-2031 | 6.04% |
| Fastest Growing Segment | Outpatient Facilities |
| Largest Market | North America |
Market Driver
The rising prevalence of chronic ophthalmic disorders acts as a fundamental catalyst for the Global Ophthalmic Lasers Market, with an aging demographic and lifestyle changes accelerating conditions like myopia and cataracts, thereby expanding the patient pool eligible for laser-based treatments. The British Journal of Ophthalmology, in October 2024, projected global myopia prevalence to reach nearly 40% by 2050, underscoring significant long-term demand for corrective ophthalmic procedures. Further propelling the market is a surge in the adoption of refractive and cataract surgeries; healthcare facilities are actively procuring advanced surgical systems to manage increasing procedural volumes, leading to improved financial performance for leading device manufacturers, as seen with Alcon's surgical net sales increasing 4% to $5.5 billion for 2024 and Bausch + Lomb's surgical segment growing 10% to $843 million in 2024, highlighting robust global commercial uptake.
Market Challenge
A major impediment to the growth of the global ophthalmic lasers market is the significant acquisition cost of advanced laser platforms. This substantial capital investment creates a barrier for smaller clinics and healthcare facilities, particularly in developing regions with limited financial resources. Consequently, many providers prolong the use of existing equipment rather than upgrading, which directly curtails new unit sales and slows market penetration of innovative laser systems. This economic pressure is exacerbated by tightening reimbursement models that reduce practices' net income and available capital; for instance, ophthalmologists faced an approximate 2.8% Medicare payment reduction in 2025, according to the American Academy of Ophthalmology, creating a fiscally constrained environment that discourages expensive device acquisitions and hinders market expansion.
Market Trends
A fundamental shift towards flapless refractive lenticule extraction procedures is reshaping the corneal surgery landscape, moving beyond traditional flap-based LASIK with increasing preference for minimally invasive techniques like SMILE and SILK due to superior biomechanical stability and reduced post-operative dry eye. The commercial viability of this segment is reinforced by the expansion of proprietary platforms from key manufacturers. Carl Zeiss Meditec's Ophthalmology Strategic Business Unit reported an 8.5% revenue increase to €1.72 billion in its 2024/25 Annual Report, largely driven by sustained demand for refractive laser solutions. Concurrently, the adoption of Selective Laser Trabeculoplasty (SLT) as a primary glaucoma treatment is gaining momentum, displacing pharmaceutical drops as the first-line standard of care. This paradigm shift, supported by strong clinical evidence for early laser intervention, is being capitalized on by industry leaders introducing automated and direct laser technologies, reflected in Alcon's Q4 2024 surgical net sales reaching $1.4 billion, underscoring robust demand for advanced surgical equipment facilitating these modern protocols.
Report Scope
In this report, the Global Ophthalmic Lasers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Ophthalmic Lasers Market.
Global Ophthalmic Lasers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: